17 November 2016 - Deborah Wilkes
Archived
Acquiring Allergan's Actavis generics business, including the international OTC unit, helped lift Teva's OTC revenue by 40% as reported to US$356 million in the third quarter of 2016.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.